✦ LIBER ✦

Antibiotics plus granulocyte colony-stimulating factor reduces febrile neutropenia in the first cycle of chemotherapy in people with small-cell lung cancer

✍ Scribed by Julia Bohlius; Andreas Engert

Book ID: 116395032
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 103 KB
Volume: 32
Category: Article
ISSN: 0305-7372
DOI: 10.1016/j.ctrv.2006.02.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reduction in the incidence of chemothera

Reduction in the incidence of chemotherapy-induced febrile neutropenia in patients with small cell lung cancer by granulocyte colony stimulating factor (r-metHuG-CSF)

📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Primary Granulocyte Colony-Stimulating F

Primary Granulocyte Colony-Stimulating Factor Prophylaxis During the First Two Cycles Only or Throughout All Chemotherapy Cycles in Patients With Breast Cancer at Risk for Febrile Neutropenia

✍ Aarts, M. J.; Peters, F. P.; Mandigers, C. M.; Dercksen, M. W.; Stouthard, J. M. 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 189 KB

The limits of chemotherapy dose intensif

The limits of chemotherapy dose intensification using Granulocyte Colony Stimulating Factor alone in extensive small cell lung cancer

✍ Trillet-Lenoir, V.; Soler, P.; Arpin, D.; Bohas, C.; Riou, R.; Court-Fortune, I. 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 686 KB

Efficacy of recombinant human granulocyt

Efficacy of recombinant human granulocyte-macrophage colony-stimulating factor for chemotherapy-induced leukopenia in patients with non-small-cell lung cancer

✍ K. Eguchi, J. Kabe, S. Kudo, K. Mano, H. Morinari… 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 756 KB

Received dose-intensity: A randomized tr

Received dose-intensity: A randomized trial of weekly chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Schedule of granulocyte colony stimulati

Schedule of granulocyte colony stimulating factor (G-CSF) in dose intensive chemotherapy with cisplatin, etoposide, mitomycin in non-small cell lung cancer (NSCLC)

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 145 KB